AmerisourceBergen

Courtesy of AmerisourceBergen
  • Previous Rank
    12
  • Revenues ($M)
    146850
  • Revenue Percent Change
    8
  • Profits ($M)
    1427.9
  • Profits Percent Change
  • Assets ($M)
    33656
  • Employees
    18500
  • Market Value — as of March 31, 2017 ($M)
    19229

AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it's subject to many of the same forces affecting McKesson, its top competitor. Branded drug price deflation and fewer expected new drug launches continue to put pressure on industry profits, and AmerisourceBergen has been working to counter those effects. The company was founded in 1985 and is headquartered in Chesterbrook, Penn.

Company Info

CEOSteven H. Collis
CEO TitleChairman, President & Chief Executive Officer
SectorWholesalers
IndustryWholesalers: Health Care
HQ LocationChesterbrook, PA
Websitewww.amerisourcebergen.com
Years on Fortune 500 List23
Employees18,500

Key Financials (Last Fiscal Year)

Revenues ($M)$146,850
Profits ($M)$1,427.9
Assets ($M)$33,656
Total Stockholder Equity ($M)$2,129
Market Value — as of March 31, 2017 ($M)$19,229

Profit Ratios

Profit as % of Revenues1%
Profits as % of Assets4.2%
Profits as % of Stockholder Equity67.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)6
EPS % Change (from 2015)-
EPS % Change (5 year annual rate)20%
EPS % Change (10 year annual rate)18.8%

Total Return

Total Return to Investors (2016)-23.3%
Total Return to Investors (5 year, annualized)17.7%
Total Return to Investors (10 year, annualized)15%